U.S. Hormone Replacement Therapy Market Size Report, 2032

U.S. Hormone Replacement Therapy Market - By Product (Estrogen, Progesterone, Thyroid, Growth Hormone, Testosterone), Route of Administration (Oral, Parenteral), Disease (Menopause, Growth Hormone Deficiency), Distribution Channel, Forecast 2023-2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market definition

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3&nbsp;&nbsp;&nbsp; Forecast calculation

1.4&nbsp;&nbsp;&nbsp; Covid-19 impact analysis at global level

1.5&nbsp;&nbsp;&nbsp; Data validation

1.6&nbsp;&nbsp;&nbsp; Data sources

1.6.1&nbsp;&nbsp;&nbsp; Primary

1.6.2&nbsp;&nbsp;&nbsp; Secondary

1.6.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.6.2.2&nbsp;&nbsp;&nbsp;Public sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; U.S. hormone replacement therapy industry 360&ordm; synopsis, 2018 &ndash; 2032 (USD Million)

2.1.1&nbsp;&nbsp;&nbsp; Business trends

Chapter 3&nbsp;&nbsp;&nbsp;U.S. Hormone Replacement Therapy Market Insights

3.1&nbsp;&nbsp;&nbsp; Industry landscape, 2018 &ndash; 2032 (USD Million)

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Increasing geriatric population

3.2.1.2&nbsp;&nbsp;&nbsp;Rising awareness of post-menopausal issues

3.2.1.3&nbsp;&nbsp;&nbsp;Increasing development of novel drug delivery systems for hormone imbalance issues

3.2.1.4&nbsp;&nbsp;&nbsp;Rising prevalence of hormonal disorders

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;High cost associated with hormone replacement therapy

3.2.2.2&nbsp;&nbsp;&nbsp;Adverse effects of hormone replacement therapy

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By product

3.3.2&nbsp;&nbsp;&nbsp; By route of administration

3.3.3&nbsp;&nbsp;&nbsp; By disease type

3.3.4&nbsp;&nbsp;&nbsp; By distribution channel

3.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.6&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.7&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.3&nbsp;&nbsp;&nbsp; Competitive analysis of major market players, 2022

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix, 2022

4.5&nbsp;&nbsp;&nbsp; Strategic dashboard, 2022

Chapter 5&nbsp;&nbsp;&nbsp;U.S. Hormone Replacement Therapy Market Estimates and Forecast, By Product, 2018 - 2032 (USD Million)

5.1&nbsp;&nbsp;&nbsp; Key trends, by product

5.2&nbsp;&nbsp;&nbsp; Estrogen &amp; progesterone replacement therapy

5.3&nbsp;&nbsp;&nbsp; Thyroid replacement therapy

5.4&nbsp;&nbsp;&nbsp; Growth hormone replacement therapy

5.5&nbsp;&nbsp;&nbsp; Parathyroid hormone replacement therapy

5.6&nbsp;&nbsp;&nbsp; Testosterone replacement therapy

Chapter 6&nbsp;&nbsp;&nbsp;U.S. Hormone Replacement Therapy Market Estimates and Forecast, By Route of Administration, 2018 - 2032 (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by route of administration

6.2&nbsp;&nbsp;&nbsp; Oral

6.3&nbsp;&nbsp;&nbsp; Parenteral

6.4&nbsp;&nbsp;&nbsp; Other routes of administration

Chapter 7&nbsp;&nbsp;&nbsp;U.S. Hormone Replacement Therapy Market Estimates and Forecast, By Disease Type, 2018 - 2032 (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, by disease type

7.2&nbsp;&nbsp;&nbsp; Menopause

7.3&nbsp;&nbsp;&nbsp; Growth hormone deficiency

7.4&nbsp;&nbsp;&nbsp; Male hypogonadism

7.5&nbsp;&nbsp;&nbsp; Hypothyroidism

7.6&nbsp;&nbsp;&nbsp; Hypoparathyroidism

7.7&nbsp;&nbsp;&nbsp; Other disease types

Chapter 8&nbsp;&nbsp;&nbsp;U.S. Hormone Replacement Therapy Market Estimates and Forecast, By Distribution Channel, 2018 - 2032 (USD Million)

8.1&nbsp;&nbsp;&nbsp; Key trends, by distribution channel

8.2&nbsp;&nbsp;&nbsp; Hospital pharmacies

8.3&nbsp;&nbsp;&nbsp; Retail pharmacies

8.4&nbsp;&nbsp;&nbsp; Online pharmacies

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Eli Lilly and Company

9.2&nbsp;&nbsp;&nbsp; Bayer AG

9.3&nbsp;&nbsp;&nbsp; Pfizer Inc.

9.4&nbsp;&nbsp;&nbsp; Viatris, Inc.

9.5&nbsp;&nbsp;&nbsp; Noven Pharmaceuticals, Inc.

9.6&nbsp;&nbsp;&nbsp; Merck KGaA

9.7&nbsp;&nbsp;&nbsp; Novo Nordisk A/S

9.8&nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche Ltd.

9.9&nbsp;&nbsp;&nbsp; ASCEND Therapeutics US, LLC.

9.10&nbsp;&nbsp;&nbsp; Abbott Laboratories

9.11&nbsp;&nbsp;&nbsp; Teva Pharmaceutical Industries Ltd.

9.12&nbsp;&nbsp;&nbsp; Novartis AG 
&nbsp;

U.S. Hormone Replacement Therapy Market

Customize This Report